Showing 1 - 1 results of 1 for search 'Madeline Richey', query time: 0.01s Refine Results
  1. 1
    Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study

    Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study by Dana M. Chase, Maya Hanna, Jonathan T. Lim, Tirza Areli Calderón Boyle, Mark Guinter, Madeline Richey, Khilna Patel, Jeanne M. Schilder, Jean A. Hurteau, Amanda K. Golembesky

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: